Malignant lymphomas as tumours of the immune system. by Berard, C. W. et al.
Br. J. Cancer (1980) 42, 1
Walter Hubert Lecture, delivered 1 April 1980 to the 21st AGM of the BACR
by Dr Costan W. Berard
MALIGNANT LYMPHOMAS AS TUMOURS
OF THE IMMUNE SYSTEM
C. W. BERARD, J. COSSMAN AND E. S. JAFFE
From the Hematopathology Section, Laboratory ofPathology, National Cancer Institute,
Bethesda, Maryland 20205, U.S.A.
Summary.-Malignant lymphomas have traditionally been classified on solely
morphological grounds. With new immunological and cytochemical techniques, it
has been possible to characterize normal cells of the T-lymphocyte, B-lymphocyte,
and monocyte-macrophage system. Application ofthese methodologies to malignant
lymphomas has established their nature as neoplasms of the immune system.
Within the B-lymphocyte system it is possible to identify subpopulations responsible
for Burkitt's tumour, follicular (nodular) lymphomas, lyn*phocytic lymphomas of
intermediate differentiation and well differentiated lymphocytic lymphomas. The
T-lymphocyte system includes lymphoblastic lymphomas, mycosis fungoides, and
Sezary's syndrome. Large-cell lymphomas are diverse, but the majority are tumours
oftransformed lymphocytes, usually ofthe B-lymphocyte system. The precise nature
ofthe neoplastic cells ofHodgkin's disease (i.e., Reed-Sternberg cells and their mono-
nuclear counterparts) has not yet been established. Despite previous suggestions of a
B-lymphocyte or T-lymphocyte origin, recent studies with in vitro cultivation have
strongly suggested derivation from the monocyte-macrophage system.
MALIGNANT LYMPHOMAS have been tra-
ditionally diagnosed and classified on the
basis of solely morphological criteria.
Clinicopathological studieshaverepeatedly
shown the applicability and value of the
Rappaport classification (Rappaport,
1966) with recent modifications (Nathwani
et al., 1976; Pangalis et al., 1977; Mann
et al., 1979) (Table I), for the non-Hodg-
kin's lymphomas. The classification of
Hodgkin's disease (HD) originally prof-
fered by Lukes & Butler (1966) and
Lukes et al. (1966a) and later simplified
by a nomenclature committee (Lukes
et al., 1966b) (Table II) has simultaneously
gained world-wide acceptance and usage.
In recent years, however, new immuno-
logical, cytochemical, and ultrastructural
techniques have made possible a sophisti-
cated characterization of normal cells of
the T-lymphocyte, B-lymphocyte, and
monocyte-macrophage series (Mann et al.,
1979). Such studies have greatly enhanced
1
current understanding of the compart-
mentalization, immunology and function
of the lymphoreticular system. Use of the
same modern methodologies in studies of
the neoplastic cells of malignant lympho-
mas has established that such cells often
bear markers similar or identical to those
demonstrable on normal cells. Malignant
lymphomas are tumours of the immune
system (Table III) and they often seem,
both structurally and functionally, to be
neoplastic caricatures of their normal
benign counterparts (Lukes & Collins,
1974; Berard et al., 1976, 1978; Lukes et
al., 1978a, b; Mann et al., 1979).
In our laboratory we have evaluated the
neoplastic cells in suspension for spon-
taneous rosette (E) formation with sheep
red blood cells (SRBC), receptors for com-
plement (EAC), receptors for cytophilic
antibody (IgGEA), and surface immuno-
globulins (SIg). Bothpolyvalentandmono-
valent antisera have been used to charac-C. W. BERARD, J. COSSMAN AND E. S. JAFFE
TABLE 1.-Classifcation of non-Hodykin's
lymphomaas
Nodular (follicular) lymphomas
Lymphocytic, poorly differentiated]
Mixedl lymphocytic-"histiocytic"
"Histiocytic"
Diffuse lymphomas
Lymphocytic, well differentiated
Lymphocytic, intermediate differentiation
Lymphocytic, poorly differentiatedl
Mixed lymphocytic-"histiocytic"
"Histiocytic"
Undifferentiated, Burkitt's type
Undifferentiated, pleomorphie (non-Burkitt's)
Lymphoblastic
TABLE II. Classification of Hodgkin's
disease
Nodular sclerosis
Lymphocytic predominance
Mixedl cellularity
Lymphocytic (lepletion
terize SIg. All suspensions have been sub-
sequently examined on stained cyto-
centrifuge preparations for cytological
identification ofrosetted and non-rosetted
cells and direct comparison with routine
histological sections ofthe tumours. Frozen
sections (FS) have been reacted with E,
EAC, or IgGEA to determine the precise
location of rosetted and non-rosetted cells
within the neoplasms. To demonstrate
relevant hydrolytic enzymes we have used
histochemical and cytochemical methods
on FS and cytocentrifuge preparations,
respectively. Inthispaperwepresent, from
boththe recent extensive literature on such
studies (Lukes et al., 1978a,b; Mann et al.,
1979) and our own data as selected exam-
ples, the major characteristics of the cells
of these neoplastic proliferations.
NODULAR (FOLLICULAR) LYMPHOMAS
Among the non-Hodgkin's lymphomas,
nodular (follicular) lymphomas are charac-
terized by a propensity of the neoplastic
cells to form cohesive aggregates resemb-
ling lymphoid follicles or germinal centres
(Rappaport, 1966). On the basis of their
cytological diversity they are subelassified
into 3 groups (Table I). Most common are
the lymphocytic, poorly differentiated
group, in which the predominant cells are
small and cytoplasm is scant. The most
distinctive feature of the neoplastic cells is
their indented or "cleaved" nuclear con-
figuration, with moderately condensed
chromatin, small nucleoli, and few mitotic
figures. Although usually widespread at
the time of clinical presentation (Chabner
etal., 1977), these neoplasms have the most
favourable prognosis of the nodular lym-
phomas (Jones et al., 1973; Qazi et al.,
1976). Clinically most aggressive are the
uncommon nodular "histiocytic" group,
even though they are at diagnosis more
frequently localized (Stage I or II) than
other nodular lymphomas (Jones et al.,
1973; Chabner et al., 1977). If therapy
does not induce a complete clinical remis-
sion, these neoplasms are characteristically
rapidly progressive and fatal. Histologic-
ally they show a predominance of large
cells, usually with round to oval vesicular
nuclei and 1-3 prominent basophilic
nucleoli. A striking feature is the tendency
for one or more ofthe nucleoli to be located
in apparent apposition to the sharply
defined nuclear membrane. Mitoses are
numerous, and most cells have a readily
detectable rim of amphophilic cytoplasm
(basophilic or pyroninophilic with special
stains). A variable proportion of the large
cells have indented or folded nuclei, with
small nucleoli, coarse chromatin, and
narrow margins of pale cytoplasm. Ad-
mixed with the large neoplastic cells there
may be normal-appearing tingible-body
macrophages and a smattering of small
cleaved" cells identical to those of the
nodular lymphocytic, poorly differentiated
group. In tumours of the mixed lympho-
cytic-"histiocytic" group there is a more
balanced admixture of large and small
neoplastic cells, with mitotic activity
generally paralleling the numerical fre-
quency of the former. While sometimes
comprising adistinct minorityofthe malig-
nant population, the large cells should be
conspicuous (10 or more in most high-
power fields) in any nodular lymphoma
classified as mixed.
Despite the cytological and architec-
tural resemblance of nodular lymphomas
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TABLE III. Summary of markers of lymphoreticular malignancies
Marker
B-cell
T-cell
Heterogeneotis
Well-differentiated lymphocytic malignancies
Chronic lymphocytic leukaemia (98%)
WA'ell-differentiated lymphocytic lymphoma
Waldenstrom's macroglobulinaemia
Lymphocytic lymphoma, intermediate differentiation
Nodular (follicular) lymphoma
Burkitt's lymphoma
Lymphoblastic lymphoma
Acute lymphoblastic leukaemia (250%)
Mycosis fungoides/Sezary's syndrome
Chronic lymphocytic leukaemia (20%)
Large-cell lymrphomas
"Histiocytic" lymphoma
Mixed lymphocytic-"histiocytic" lymplioma
Undifferentiated, pleomorphic (non-Burkitt's) lymplioma
Not settled Hocdgkin's disease
to normal lymphoid follicles, their precise
cellular origin cannot be established solely
on morphological grounds. With know-
ledge provided by newer techniques, how-
ever, it is now unequivocally proved that
all nodular lymphomas are composed of
neoplastic follicular B lymphocytes
(Kojima et al., 1973; Lennert, 1973; Jaffe
et al., 1974a, b; 1975; Leech et al., 1975;
Levine & Dorfman, 1975; Berard et al.,
1976) (Table III). We have earlier reported
the presence on the neoplastic cells ofavid
complement receptors, also characteristic
of normal follicular B lymphocytes (Jaffe
et al., 1974a). Other investigators have
found readily demonstrable SIg, usually
of the IgM class with or without IgD
(Aisenberg & Long, 1975; Leech et al.,
1975). In any nodular lymphoma all the
malignant cells belong immunologically
to a single clone of follicular B lympho-
cytes. Our series has enlarged to a total of
49 specimens from 36 patients, confirming
earlier observations (Table IV). Strong
adherence ofEAC, both in suspensions and
on frozen sections, was present in 48 ofthe
49. Of 32 studied for SIg, all but one had
bright staining of the neoplastic cells.
Fifteen were tested for individual light
and heavy chains (i.e., K, A, IgM, IgG and
IgA). In every case the SIg was mono-
clonal, with only one light chain. IgM was
present in 13 of the 15. In 2 only K light
chains were found, but these were not
evaluated for IgD. Of 5 studied for IgD,
TABLE IV. Markers ofnodular (follicular)
lymphomas (49 samples from 36 indi-
viduals)
EAC
SIg
E
48/49
31/32
Strong
Briglit
MNonoclonal 1.
IgM (with either K or A) 1.
IgD (with or without IgM)
38% Mean*
grosettes
t staining
5/15
3/15
2/5
Abbreviations:
EAC, erythrocyte-anltibody-complement rosettes;
SIg, surface immunoglobulin;
E, rosette formation with unsensitized sheep
erythrocytes.
*Marker not demonstrated on neoplastic cells.
2 were positive and in one of these both
IgD and IgM were demonstrable with
solely K light chains. The combined pre-
sence of surface-bound IgD and IgM has
been seen in other B-lymphocyte
neoplasms, most frequently in chronic
lymphocytic leukaemia (CLL) and does
not nullify the monoclonality of these
tumours (Fu et al., 1974). With the use of
anti-idiotypic antibody, the IgD and IgM
have been shown to share the same idio-
type and even the same antibody speci-
ficity.
The cells of all 3 cytological groups
have identical B-lymphocyte surface mar-
kers, and the older designation "histio-
cytic" (Rappaport, 1966) is an unfortunate
misnomer resulting from a superficial
resemblance of the nuclear features of the
large neoplastic cells to those seen in nor-
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mal activated histiocytes. In frozen sec-
tions exposed to EAC, the rosetted cells
are frequently exclusively confined to the
malignant nodules (Jaffe et al., 1974a).
Although comprising immunologically a
single neoplastic population, the large and
small follicular B lymphocytes probably
represent kinetic variants (Braylan et al.,
1978). The large cells are the replicative
fraction, and their numerical frequency
parallels the mitotic activity and clinical
aggressiveness of the tumour. Sequential
biopsies from the same patient may show
either constancy of "histological progres-
sion" ofthe process. In the latterevent, the
shift is usually towards a prognostically
graver form, i.e., from a nodular to a
diffuse pattern ofgrowth and/or from small
to large neoplastic cells (Cullen et al.,
1979; Risdall etal., 1979; Woda& Knowles,
1979). Despite these alterations in histo-
logy and apparent kinetic activity, the
cells ofsuch tumours retain their follicular
B-lymphocyte markers (Berard et at.,
1978; Woda & Knowles, 1979). An under-
standing of their evolution enables one to
account for apparently de novo diffuse
lymphomas of the poorly differentiated
lymphocytic, mixed lymphocytic-"histio-
cytic", and "histiocytic" types with
immunological markers identical to those
of nodular lymphomas.
Notwithstanding the fact that the malig-
nant cells are follicular B lymphocytes, in
nodular lymphomas there are usually
numerous admixed cytologically normal T
cells (mean 38%, Table IV). In our
laboratory, pretreatment lymph nodes
involved by nodular lymphoma have
contained a mean of 41 + 13% E-rosette-
forming cells (ERFC) (Table V). In
recurrences after treatment the mean
percentage of ERFC was somewhat re-
duced (34 + 19%). There is no present
evidence to implicate these T cells as part
of the neoplastic proliferation, since they
are invariably normal in appearance. On
the basis of early studies we had hypothe-
sized that the T cells wereprobably located
in the internodular areas, which histo-
logically appeared to be populated by
TABLE V. T tymphocytes in nodular
lymphontams (mean + s.d.)
% E
EN on
frozen
sections
Before treatment
Lymph ino(les (11)
41 + 13
Spleens (3)
42+9
After treatment
Lymplh Iocdes (12)
34 + 19
Spleens (4)
27 + 12
Lymph io(les Lymph Ino(les
8/11 nodtular or 7/12 nocIular or
perinodular perinoflular
3/11 internodular 5/12 interno(dular
Spleens Spleens
3/3 perifollicular 3/4 perifollicular
predominantly normal-looking lympho-
cytes. Moreover, with progressive replace-
ment of the nodal parenchyma by neo-
plastic nodules, the percentage of ERFC
was proportionally diminished (Jaffe et al.,
1974a). A direct approach to the question,
however, had to await a method for identi-
fying and localizing T cells in frozen sec-
tions.
We have recently used on nodular
lymphomas a slight modification of the
method of Tonder et at. (1974) for identi-
fying ERFC in frozen sections. As pre-
viously detailed (Weiner et al., 1973),
SRBC were pretreated with neuraminidase
(EN). Frozen sections were incubated at
4°C for 18 h with a suspension of 0 5%O E
in 20% heat-inactivated foetal calf serum
(previously absorbed with SRBC). After
incubation the sections were inverted for
30 min at 4°C and then evaluated micro-
scopically without fixation. All sections
were interpreted in parallel with serial
frozen sections stained with haematoxylin
and eosin. The studies included 23 lymph
nodes involved by nodular lymphoma of
poorly differentiated lymphocytic (NPDL)
or mixed lymphocytic-"histiocytic" (NM)
types. Eleven nodes were biopsied before
any treatment while 12 were post-treat-
ment recurrences. Also tested were 7
spleens involved by NPDL, 3 before and
4 after treatment. Used as control tissues
were normal or reactive lymph nodes and
spleens, normal thymus gland, and lymph
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nodes diffusely infiltrated by chronic
lymphocytic leukaemia ofB-cell type with
negligible numbers of residual T cells in
cellular suspensions. All specimens evalua-
ted by the frozen-section method were also
studied in suspension to determine the
% ofT cells (Table V). In lymph nodes the
mean ERFC was 41 + 13 before treat-
ment and 34 + 19 in recurrences. In
spleens the mean ERFC was 42+ 9
before and 27 + 12 after treatment.
Contrary to our expectation, in lymph
nodes involved by nodular lymphoma the
strongest reactions with EN were not
internodular. Rather, they were within
the nodules, particularly at their periphery
(Table V). In most cases these perinodular
reactions were very striking and con-
formed to the configuration of the nodules
with less binding of EN in the central
portions. Lymph nodes biopsied before or
after therapy had the same patterns of
localization. Of 11 studied before therapy,
8 had nodular or perinodular reactions
greater than or at least equal to the inter-
nodular reactions. In only 3 cases were
the nodules negative with the adherent E
being predominantly internodular. In the
post-treatment lymph nodes the nodular
or perinodular reactions were generally
weaker but were still readily discernible in
7/12 cases. In 5 the nodules were negative
and the predominant reactions were inter-
nodular.
In spleens involved by nodular lym-
phoma the findings differedsomewhatfrom
those in lymph nodes. The central portions
of the Malpighian follicles, histologically
populated by malignant cells, manifested
only weakly positive reactions. The reac-
tions were strongest at the periphery ofthe
white pulp, a zone thought to be populated
normally by T cells (Craddock et al., 1971).
In spleens involved by nodular lymphoma,
however, the peripheral T-cell reactions
were much greater than those in any ofthe
normal control spleens. Histologically the
reactions appeared to correlate with a
distinct zone containing lymphocytes and
prominent immunoblasts. Only one case,
which lacked this hyperplastic zone,
failed to show a peripheral white-pulp
reaction.
The strong binding ofEN to the nodules
ofnodular lymphoma was not anticipated,
and made it essential to confirm that the
binding was dueto the interaction ofSRBC
and T lymphocytes. Reactions in control
tissues were consistent with this conclu-
sion. There were very strong reactions in
sections between thymocytes and EN.
Conversely, there was essentially no bind-
ing ofEN (with only rare isolated rosettes)
to frozen sections of tissues infiltrated by
CLL ofB-cell type. Additional procedures,
performed on tissues involved by nodular
lymphoma, also supported the specificity
of the observed reactions. Binding was
inhibited by prior trypsinization of the
SRBC, a procedure known to abolish E
rosetting (Weiner et al., 1973). It was sug-
gested that the SIg of the neoplastic cells
might be mediating the binding via anti-
body activity against SRBC, butbindingof
E in an identical pattern persisted after
preincubation of frozen sections with
anti-human immunoglobulini. Moreover,
the one case of nodular lymphoma that
was SIg-negative exhibited equally strong
binding of EN. Additional reactions were
carried out with human and rabbit red
cells, since both human and rhesus monkey
but not rabbit red cells have been reported
to interact with human T lymphocytes in
a manner similar to SRBC (O'Connell,
1973; Lohrman & Novikovs, 1974; Bra-
ganza et al., 1975; Sandilands et al., 1975).
With human red cells the reaction was
weaker but qualitatively similar to that
obtained with SRBC. The rabbit red
cells, however, failed to manifest any
specific patterns of binding to frozen
sections.
All observations to date thus indicate
the frequent presence of E-binding T
lymphocytes in a nodular or perinodular
distribution in tissues involved by nodular
lymphoma. One can only speculate upon
the significance of this finding. These T
cells may well be reactive, since the ERFC
on cytocentriftige preparations are always
cytologically normal. Moreover, in diffuse
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"histiocytic" lymphomas occurring as
"histological progression" fronm priornodu-
lar lymphomas, the percentages of ERFC
are almost always low (Table VIII). Even
in recurrent tumours which retain a
nodular pattern, the % of ERFC tends to
be lower than that in pretreatment biop-
sies (Table V). The T cells may be a
manifestation of host defence since T-
lymphocyte infiltrates have been seen in
other malignant tumours (Potvin et al.,
1975). Also unexplained is the relatively
poor binding of EN to the internodular
areas. These areas fail to bind EAC and are
usually rich in normal-looking lympho-
cytes ofpresumed T-cell type. It is known
that activated T lymphocytes appear to
bind E more readily than T cells not
stimulated or not actively involved in an
immunological reaction (Wybran et al.,
1972). The so-called "active E rosette
test" is based upon this observation
(Wybran et al., 1972). Perhaps the small
lymphocytes in the internodular areas are
an inactive, unstimulated population of
T cells with little or no affinity for EN in
frozen sections. Conceivably, those T cells
which do bind EN in a nodular or peri-
nodular pattern in the frozen-section assay
may be a subpopulation of stimulated,
immunologically active cells. Future
studies of nodular lymphomas should
include assays of the E-active population
in cellular suspensions. As more cases are
studied it may be possible to demonstrate
hitherto unsuspected correlations between
the T-cell component of nodular lym-
phomas and their clinical and pathological
manifestations.
DIFFUSE LYMPHOMAS
Malignant lymphomas with a diffuse
pattern ofgrowth are morphologically and
clinically heterogeneous (Rappaport, 1966;
Mann et al., 1979). This heterogeneity
reflects the fact that they, unlike nodular
lymphomas, are not a generic group.
Sharper insights into this spectrum of
tumours have evolved from recent immu-
nological and cytochemical studies.
Lymphocytic, well differentiated
Occurring predominantly in older age
groups, these tumours are usually dis-
seminated at the time of clinical presenta-
tion (Pangalis et al., 1977). Despite docu-
mentation of Stage IV disease, with fre-
quent microscopic involvement of liver
and/or marrow, the patients may be
remarkably asymptomatic and the disease
may have an indolent clinical course. The
neoplastic cells are predominantly small
round lymphocytes with scant cytoplasm,
clumped chromatin, small nucleoli, and
only rare mitotic figures. Seen amidst
them are scattered large cells with round
vesicular nuclei and 1-2 prominent nu-
cleoli. In some patients these large cells
are more numerous and they may tend to
cluster in ill-defined foci which appear
pale and mottled at low magnification.
Referred to as pseudofollicular "growth
centres" (Mann et al., 1979) they lack the
apparent cohesiveness and sharply defined
margins often present in the nodules of
nodular (follicular) lymphoma. The finding
of a binucleate large cell may erroneously
suggest a diagnosis of lymphocyte-pre-
dominant Hodgkin's disease, since the
lymphocytes of these lymphomas, like
those ofH.D., do not appear cytologically
malignant. The histology, however, is in
general much more monomorphic and
bland than that characteristic of H.D.
This fact, coupled with marked differences
between the 2 in presenting signs and
symptoms, usually allows for ready dis-
tinction on both clinical and morphological
grounds.
Biopsies from patients with well dif-
ferentiated lymphocytic lymphoma have
long been known to be indistinguishable
from the tissue infiltrates of CLL (Pan-
galis et al., 1977). Considering the clinical
similarities and even overlaps between
such patients, it seems that both processes
are simply clinicopathological variants of
a single neoplastic disorder. Immuno-
logical studies have lent strong support to
this belief. In our experience, the cells of
well-differentiated lymphocytic lymphoma
(WDLL) have borne monoclonal B-cell
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TABLE VI.-Markers ofCLL and WDLL
Clhronic Well (lifferentiated1
lymphocytic lymphocytic
leukaemia lymphoma
(14) (14)
Slg Weakly positive WVeakly positive
(Faint-staining) (Faint-staining)
EAC Weakly positix e in Weakly positive in
suspension suspension. Absent
or poor binding to
FS
E Reduiced Reduced
markers (Braylan et at., 1976) identical to
those widely observed on the cells of CLL
(Aisenberg et al., 1973; Aisenberg &
Wilkes, 1976; Braylan et al., 1976) (Table
VI). A small percentage of cases of CLL,
however, have shown T-cell markers and
some distinctive clinical and cytological
features (Brouet et al., 1975). Whilst the
neoplastic B cells of nodular (follicular)
lymphoma bear abundant SIg and avid
complement receptors, the small B cells
of WDLL and CLL manifest either quali-
tative deficiencies in expression of these
markers. Their monoclonal SIg is of low
density and frequently difficult to detect
or to quantitate (Aisenberg & Wilkes,
1976; Braylan et al., 1976). The SIg has
in most cases been IgM, with either K or A
light chains. It is not uncommon to find
both IgM and IgD, but the light chain is
restricted to a single class. The deficiency
in complement receptors (Logue & Cohen,
1977) is manifested as "weak" binding of
EAC in cellular suspensions and little to
no binding of this reagent to frozen sec-
tions oftumour (Braylan et al., 1976).
Morphologically and immunologically,
the cells of WDLL and CLL simulate the
small lymphocytes of the medullary cords
of normal lymph nodes. Such cells are
normally in free exchange with the peri-
pheral blood, and it is a natural biological
consequence that tumours composed of
their neoplastic counterparts are usually
either disseminated (WDLL) or overtly
leukaemic (CLL) at diagnosis (Pangalis
et al., 1977). Well differentiated lympho-
cytic neoplasms, whether leukaemic or
not, always proliferate in a diffuse pattern,
because their B cells are at a stage func-
tionally distinct from that of the follicular
B lymphocytes comprising nodular (folli-
cular) lymphomas. While such small
lymphocytes are normally precursors to
secretory B cells undergoing terminal
differentiation to plasma cells, inCLLthere
is an apparent block in this maturational
sequence; clinically the patients often
have hypogammaglobulinaemia and hu-
moralimmunodeficiency (Aisenberg, 1973).
Is this maturational block attributable
to an intrinsic defect in the neoplastic B
cells? That it may not be is suggested by
a recent report by Fu et al. (1978) on the
defective helper function of the residual
T cells in CLL. In an in vitro assay such
T cells failed to subserve a helper function
for either CLL cells or normal tonsillar B
lymphocytes. When co-cultured with nor-
mal T cells, however, the CLL cells could
be induced to differentiate into immuno-
globulin-secreting plasma cells. At present
it is unknown whether this T-cell defect
is primary or secondary, but there is no
evidence to implicate the T cells as part of
the neoplastic proliferation.
In some well differentiated lymphocytic
malignancies the block in maturation
occurs at a step beyond that characteristic
of CLL. The neoplastic cells recapitulate
to varying degrees the differentiation
pathway by which medullary-cord B cells
normally mature to plasma cells. Cyto-
logically one sees a mixture of small
lymphocytes and plasmacytoid lympho-
cytes. Immunological studies reveal mono-
clonal immunoglobulin not only at the
surface but also within the cytoplasm of
the cells. The heavy-chain class is most
commonly IgM and, if the cells secrete
their monoclonal IgM in quantities detect-
able in the serum as an "M" spike, the
clinicopathological picture is that classic-
ally referred to as Waldenstrom's macro-
globulinaemia (WM) (Pangalis et al.,
1977). Notably, in the studies of this dis-
ease by Fu et at. (1978) there was no
apparent defect in the helper function of
T cells.
There is one final important point to
be made concerning all well-differentiated
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TABLE VII. Markers of lymphocytic lyrntphomas, intermediate differentiation
EAC-FS ALP,'
Case No. Tissue E* EA(' IgGEA Sig Clonality (frozen sections)
16
2 1
6
25
17
1')
76
63
80
64
76
50
85
86
18
23
6 80 MADk + + + +
7 50 Gk + + +
16 55 NI )k + +
7 61 Al + + + +
17 885 Mkt + +
36 9( AlDk + +
2 15 Nlk + + +
16 :34 MIk +++
+
+
* Results are expresse(t as positive cells.
t Not studied for IgD.
t LN, lymph node; SPL, spleen.
lymphocytic malignancies (WDLL, (CLL,
WM). Whether or not they are secretory,
neoplasms of these small B lymphocytes
may occasionally transform or "progress"
to large-cell tumours which appear cyto-
logically either "blastic" or "histiocytic".
As with nodular (follicular) lymphomas,
immunological studies have shown that the
large cell neoplasms which supervene still
retain markers of the pre-existent and
underlying B-lymphocytic proliferation
(Brouet et al., 1]974; 1976).
Lymphocytic, intermediate differentiation
Lymphocytic lymphomas of inter-
mediate differentiation are an uncommon
but distinctive entity within the spectrum
ofnon-Hodgkin's lymphomas (Mann et al.,
1979). They occur predominantly in the
older age groups also at risk for nodular
(follicular) lymphomas and well differen-
tiated lymphocytic malignancies (WDLL,
CLL, WM). Pathologically these neoplasms
manifest features intermediate between
WDLL and nodular (follicular) lympho-
mas of the poorly differentiated lympho-
cytic type (NPDL). There may be a
subtle, vague nodularity, but the pattern
ofgrowth is usually diffuse. The malignant
cells are small and generally monomor-
phous with clumped chromatin and sparse
cytoplasm. The nuclei, however, range in
shape from small, round ones similar to
WDLL to somewhat "cleaved" or in-
dented forms similar to those characteris-
tic of NPDL. Because of their mixed
nuclear features these neoplasms have
traditionallv been difficult to classify.
Solely on the basis of individual concept
and preference, different observers have
arbitrarily assigned them to either the well
differentiated or the poorly differentiated
lymphocytic categories.
Immunologically these tumours also
appear to be intermediate between WDLL
and NPDL. Table VII summarizes the
data of 6 such cases. All bore B-lympho-
cyte markers. The cells had monoclonal
SIg, most commonly with an IgM heavy
chain. In 2 there was also a minority of
cells with IgD. One case bore surface IgG.
The fluorescent staining was readilydetect-
able and of intermediate intensity relative
to NPDL and XVDLL. The cells also had
complement receptors and bound EAC
relatively well, both in cellular suspen-
sions and in frozen sections. The per-
centage of ERFC was usually low, lower
than in nodular (follicular) lymphomas,
and was consistent with the diffuse replace-
ment seen histologically. One case [No.
277] was atypical, in that the neoplastic
process only focally involved the tissues.
In both lymph nodes and spleen there was
an extensive co-existent non-caseating
granulomatous reaction. This mixed reac-
tion was probably responsible for the high
percentage of ERFC identified in cellular
suspensions (Table VII). This case has
been previously reported in detail (Braylan
et al., 1977).
The lymphocytic lymphomas of inter-
mediate differentiation were also surveyed
for a battery of hydrolytic enzymes. Not-
ably, in 3/6 cases the neoplastic cells had
readily demonstrable alkaline phosphatase
329
325
311
275
228
277
LN
LN
LN
LN
LN
LN
LN
SPL
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(ALP) activity on their surface membranes
(Nanba et al., 1977). This enzyme has also
been identified in a small percentage of
nodular lymphomas (Nanba et al., 1977)
but is rare in lymphomas of other histo-
logical subtypes. In normal lymph nodes
ALP is found on the surface membranes of
lymphocytes of primary follicles and
lymphoid cuffs around germinal centres,
but not on lymphoid cells in other areas.
Lymphocytic lymphomas of intermediate
differentiation thus appear on histological,
immunological, and cytochemical grounds
to be truly intermediate between nodular
(follicular) lymphomas and WDLL. The
cells of nodular lymphomas are neoplastic
counterparts of follicular B lymphocytes,
whilst the cells of WDLL are more closely
analogous to the small B cells ofmedullary
cords. Lymphocytic lymphomas of inter-
mediate differentiation simulate (and per-
haps even arise from) B cells at the level
of primary follicles or lymphoid cuffs,
and thus have features intermediate be-
tween nodular (follicular) lymphomas and
WDLL.
Lymphocytic, poorly differentiated
The term "diffuse poorly differentiated
lymphocytic lymphoma" (DPDL) has
traditionally been applied to a hetero-
geneous spectrum of tumours which have
only recently been more clearly delineated.
Their sole unifying feature was that all
seemed to be composed ofproliferations of
atypical and presumptively "immature"
lymphocytes. At least 3 distinct neo-
plasms have now been identified within
this generic group, and others may well be
defined in future. The first is lympho-
blastic lymphomna (Nathwani et al., 1976)
historically a form ofDPDL most common
in children and young adults. This disease
has now become so well established as a
specific clinicopathological entity that it
should be diagnosed and discussed (vide
infra) separately from the remainder of
DPDL (Jaffe & Berard, 1978). The
second major tumour within DPDL
appears to be composed of follicular B
lymphocytes with an entirely diffuse pat-
tern of growth. The majority of patients
with such tumours are middle-aged to
elderly and present with localized or,
more commonly, generalized lymphadeno-
pathy. Cytologically and immunologically,
these lymphomas are composed ofa diffuse
proliferation of atypical lymphoid cells
indistinguishable from those of NPDL.
Most such tumours may have been nodular
at inception but not clinically detected
until they were in a diffuse phase. Some
biopsies from patients with this form of
DPDL contain microscopic foci ofresidual
nodularity, a finding in support of this
presumed origin. Subsequent biopsies or
staging laparotomy may yield NPDL in
lymph nodes from other sites. The presence
of B-cell markers in many of the cases
studied to date supports their hypothetical
origin from NPDL (Brouet et al., 1975;
Bloomfield et al., 1977).
The third category presently known to
exist within DPDL may arise from
peripheral T lymphocytes (Jaffe et al., 1975;
Waldron et al., 1977) in contrast to the
origin of lymphoblastic lymphomas from
thymus-committed T lymphoblasts. While
uncommon in the United States, such
tumours appear to have a greater fre-
quency in Japan (Uchiyama et al., 1977;
Suchi et al., 1979). Their clinical features
are only now being clarified, but they
occur most commonly in adults and usually
involve multiple lymphnodal regions. Ex-
tranodal dissemination to sites such as
marrow and lung has also been found.
Clinical symptoms and signs often include
anorexia, malaise, weight loss, fever, and
night sweats. The neoplastic cells usually
exhibit a broad range of size, often with
considerable variation in nuclear contours.
Some cells have deep nuclear grooves
while others contain round-to-oval vesi-
cular nuclei with 1-3 prominent nucleoli.
The cytoplasm may be abundant, sharply
demarcated, and pale to "water-clear".
Occasionally, large binucleate or multi-
nucleate forms may simulate Reed-Stern-
berg cells. The atypia of the surrounding
lymphocytes, however, clearly dis-
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tinguishes these tumours from Hodgkin's
disease. In the majority of cases there is
an admixture of cytologically non-neo-
plastic epithelioid histiocytes, either in
small aggregates or scattered singly
throughout the tumour. A consistent
feature of the series of Waldron et al.
(1977) was a prominent proliferation of
small vessels with endothelial hyperplasia.
Studies of cellular suspensions have shown
that the majority of the lymphoid cells,
including both the small lymphocytes and
the large atypical cells, form rosettes with
sheep erythrocytes, indicating a neoplastic
T-cell proliferation (Jaffe et al., 1975;
Waldron et al., 1977). Mycosis fungoides
and Sezary's syndrome, although not
included in most classifications of non-
Hodgkin's lymphomas, are also peripheral
T-lymphocyte malignancies (Brouet et al.,
1973; Flandrin & Brouet, 1974; Lutzner
et al., 1975; Robinowitz et al., 1976).
Large cell lymphomas: "histiocytic", mixed
lymphocytic-"histiocytic", and undiffer-
entiated pleormorphic (non-Burkitt's)
Diffuse lymphomas composed of large
or medium-sized cells, or a mixture of the
two have been categorized morphologically
as "histiocytic", undifferentiated pleo-
morphic (non-Burkitt's), or mixed lym-
phocytic-"histiocytic", respectively. These
tumours occur in both children and adults,
but their incidence increases with age.
Despite their propensity for extranodal
presentations and relatively localized dis-
ease (Stage I or II) at the time ofdiagnosis
(Chabner et al., 1977) in general they
pursue an aggressive clinical course with
poor prognosis (Jones et al., 1973). In
this group of patients, however, recent
trials of combination chemotheapy have
been encouraging. If therapy does yield a
well-documented complete clinical and
pathological remission, there is a good
chance for potential cure of the disease
(Schein et al., 1974, 1976; Berard et al.,
1976).
These tumouirs have marked cytological
heterogeneity, and histologically are often
difficult to classify reproducibly. Consider-
able effort has been directed to studying
their immunological and cytochemical
markers, which in published reports are
also diverse (Peter & MacKenzie, 1974;
Aisenberg & Long, 1975; Habeshaw &
Stuart, 1975; Leech et al., 1975; Morris &
Davey, 1975; Bloomfield et al., 1976;
Brouet et al., 1976; Davey et al., 1976;
Bloomfield et al., 1977; Lawrence et al.,
1978; Lukes et al., 1978a, b; Mann et al.,
1979; Pinkus et al., 1979; Suchi et al.,
1979; Woda & Knowles, 1979). About
50-60% of cases have had characteristics
of B lymphocytes, 5-15% have had mar-
kers of T lymphocytes, and only 5%0 have
had features consistent with monocytes or
true histiocytes. In about one third of
the cases the cells have lacked detectable
markers and have been termed "null" or
undefined. We have recently completed an
investigation of the surface markers and
histochemical profile of25 diffuse large-cell
lymphomas. Morphologically 18 were clas-
sified as "histiocytic", 5 as undifferentiated
pleomorphic, and 2 as mixed lymphocytic-
"histiocytic". The malignant cells were
studied in suspension for formation of
spontaneous rosettes (E) with SRBC
receptors for complement (EAC), recep-
tors for cytophilic antibody (IgGEA) and
surface immunoglobulins (SIg). Enzyme
histochemical methods on frozen sec-
tions, and cytochemical reactions on cyto-
centrifuge preparations of selected cases,
were used to detect the following hydro-
lytic enzymes: acid phosphatase (AP)
with and without tartrate, alkaline phos-
phatase (ALP), /-glucuronidase (BG) and
a battery of esterases (EST) including
oa-naphthyl acetate esterase (A-EST), cx-
naphthyl-butyrate esterase (B-EST), naph-
thol ASD chloroacetate esterase (ASDCL),
and naphthyl ASD acetate esterase
(NASDA) with and without inhibition by
sodium fluoride (NaF). In Table VIII the
immunological and histochemical features
of these cases are summarized.
B lymphocytic markers were detected
in 13/25 cases (520%). There was, however,
marked variation in the number of mar-
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kers identified, as well as in the percen-
tages of neoplastic cells bearing particular
markers. The most consistent marker was
SIg, which was present in all thoroughly
evaluated cases. In 8 cases assessed for
individual heavy and light chains, IgM
and K were identified. Surface-bound IgM
has also been the most prevalent class of
heavy chain in other B-lymphocytic
neoplasms, including nodular (follicular)
lymphoma (Aisenberg & Long, 1975;
Leech et al., 1975) chronic lymphocytic
leukaemia (Preud'Homme & Seligmann,
1972) and Burkitt's tumour (Fialkow
et al., 1973; Mann et al., 1976). These
findings are not surprising since IgM is the
immunoglobulin most frequently identi-
fied on B lymphocytes from normal peri-
pheral blood (Aisenberg, 1973). One case
bore only K light chains, without detect-
able heavy chains; however, this case was
not evaluated for the presence of IgD. In
none of these 13 B lymphocyte tumours
was there significant hydrolytic-enzyme
activity. Seven of the 25 large-cell lym-
phomas were from patients with a pre-
vious history of biopsy-proven nodular
(follicular) lymphoma; these 7 invariably
manifested B-cell markers. Such instances
of "histological progression" with reten-
tion ofmarkers appeartoreflectheightened
transformation and/or kinetic advantage
within the neoplastic population. A similar
phenomenon occurs in CML, with reten-
tion of the Ph' chromosome during blastic
transformation. Identical findings have
been reported with other lymphoid neo-
plasms, most notably blastic transforma-
tion ofCLL (Brouet et al., 1974) and large-
cell lymphomas supervening on CLL
(Richter's syndrome) (Long & Aisenberg,
1975; Brouet et al., 1976). In rare cases
with immunological studies of both the
antecedent well-differentiated prolifera-
tion and theblastictumour, themembrane-
bound immunoglobulins have shown per-
sistence ofthe same light andheavychains,
a finding which supports the concept that
both specimens belonged to a single
neoplastic clone.
T-lymphocyte markers were demon-
strated in 4/25 cases (16%,'). The malignant
cells formed E rosettes and also had
abundant granular reactivity for acid
phosphatase and 3-glucuronidase. Com-
parable enzymatic reactivity has been
observed in other T-lymphocyte neo-
plasms, including Sezary's syndrome
(Flandrin & Brouet, 1974) chronic lym-
phocytic leukaemia of T-cell type (Brouet
et al., 1975) and lymphoblastic lymphoma
(Catovsky et al., 1974; Stein et al., 1976).
Of particular interest was the fact that
1 of the 4 tumours with T-lymphocyte
markers arose suddenly in a cervical lymph
node of a 65-year-old white male with
previously well-studied Sezary's syndrome.
It was classified histologically as an
undifferentiated lymphoma of non-Bur-
kitt's type. The neoplastic cells, however,
like the patient's Sezary's cells in earlier
studies, manifested both T-cell surface
characteristics and the ability to function
as "helper" T cells for immunoblobulin
synthesis by normal B lymphocytes in
vitro (Lawrence et al., 1978). As previously
described with B-lymphocyte tumours, it
thus appears that a malignancy of more
differentiated T cells may undergo "histo-
logic progression" and yet retain surface
and fuinctional properties characteristic of
T lymphocytes.
In 1 of the 25 cases (40o) the markers
were consistent with a true h.istiocytic
neoplasm. The neoplastic cells were devoid
of SIg but formed rosettes with both EAC
and IgGEA. Additionally, they phago-
cytosed the bound erythrocytes, a pheno-
menon restricted in our experience to
cells of the monocyte-macrophage series.
They were rich in hydrolytic enzymes,
with diffuse strong cytoplasmic activity
for AP, A-EST, BG, and NASDA and
weak staining for B-EST. This neoplasm
arose in a 14-year-old boy and, unlike the
other large-cell lymphomas in this series,
appeared to be primary in bone (clavicle).
No immunological markers were detected
in the remaining 7 cases (28%); 2 ofthem,
however, were not evaluated for SIg. In 3
cases the malignant cells contained AP
and A-EST: one of these was also studied
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for BG, with positive findings. The cyto-
chemical staining pattern, however, was
not diffuse as expected with cells of the
monocyte-macrophage series. Instead, the
enzymatic reaction was manifested as
discrete punctate dots, often restricted to
the Golgi zone. This pattern of reactivity
occurs in lymphocytes, both normal and
neoplastic. It has been reported in T-cell
tumours, but these cases lacked T-cell
markers. All 3 of these cases were also
studied for and lacked terminal de-
oxynucleotidyl transferase (TdT) (Bollum,
1979). All 3 hadplasmacytoid features, and
2 examined in the electron microscope had
moderate to abundant rough endoplasmic
reticulum (Fisher et al., 1976). Strong AP
activity can be demonstrated in mature
plasma cells and the neoplastic cells of
multiple myeloma. Unlike such cells,
however, the malignant cells of these
lymphomas were devoid of demonstrable
cytopla,smic immunoglobulin. In one ofthe
"null" cases [389] attempts were made to
detect TdT, using both a biochemical assay
and indirect immunofluorescence (Bollum,
1979). Although the biochemical assay
was positive, immunofluorescence failed to
confirm this. Since, in a series ofmore than
50 cases, this is the sole instance in which
immunofluorescence failed to confirm the
biochemical assay, the positivity of this
case for TdT remains dubious.
Undifferentiated, Burkitt's type
Although there are clinical differences
between patients with Burkitt's lymphoma
in endemic areas of East Africa and those
in non-endemic regions of the world, the
tumours are histologically identical (Banks
et al., 1975). They are composed of a
strikingly uniform population of cyto-
logically "primitive" cells with character-
istic features in imprints and technically
optimal histological sections. They are
10-25 1tm in diameter and have round-to-
oval nuclei with 2-5 basophilic nucleoli.
The chromatin is coarsely reticulated and
irregularly distributed within a rather
clear parachromatin. The cytoplasm is
rich in ribosomes and consequently ampho-
philic, with a hue similar to that ofnormal
plasma cells. Special stains reveal intense
cytoplasmic pyroninophilia, sometimes
highlighting clear cytoplasmic vacuoles.
In frozen sections or air-dried imprints
some of these vacuoles contain demon-
strable neutral lipids. Mitoses are abun-
dant ( - 4% of the cells) and nuclear
pyknosis and karyorrhexis are usually
coinspicuous. Characteristically but not
invariably, tingible-body macrophages are
scattered throughout the tumour with a
resultant "starry-sky" appearance. These
features all reflect the high growth fraction
and rapid kinetics characteristic of Bur-
kitt's lymphoma (Braylan et al., 1978).
The cytological uniformity mirrors the
kinetic uniformity of the neoplastic cells.
In untreated cases the disease is very
aggressive and usually rapidly fatal, but
gratifying results have been obtained
with modern intensive chemotherapy in
both African and American patients
(Ziegler, 1977).
Immunologically the neoplastic B cells
from both patient populations are iden-
tical. They characteristically have abun-
dant monoclonal SIg, usually of the IgM
class, but inconstantly manifest receptors
for complement (Fialkow et al., 1973;
Mann et al., 1976). Within the cells there
is little or no demonstrable activity of
hydrolytic enzymes. Lukes & Collins
(1974) have likened the cells of Burkitt's
lymphoma cytologically to small non-
cleaved cells of germinal centres. To pur-
suethissuggestion,wethoroughlyreviewed
all the histopathological sections from 47
biopsy and 17 necropsy specimens, speci-
fically to assess patterns of neoplastic
proliferation in lymph nodes, spleens, and
Peyer's patches. In 10 biopsy and 2
necropsy specimens, there was selective
involvement of germinal centres by Bur-
kitt's tumour. Data both from human
cases and experiments in animals support
the concept of a relationship between the
cells of Burkitt's tumour and some B
lymphocytes of normal germinal centres
(Mann et al., 1976; Mann & Berard, 1977).
Nevertheless, the site oforigin ofBurkitt's
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lymphoma in man has yet to be conclu-
sively demonstrated.
Lymphoblastic
Lymphoblastic lymphoma is now recog-
nized as a specific clinicopathological
entity (Nathwani et al., 1976; Jaffe &
Berard, 1978) formerly included in the
generic group of diffuse poorly differentia-
ted lymphocytic lymphomas. The disease
occurs most frequently in adolescents
though there is a broad age range. Males
are affected much more often than females,
and - 50% of the patients have medias-
tinal masses at presentation. The clinical
course is rapidly progressive, with spread
of the neoplastic cells to marrow, peri-
pheral blood, and cerebrospinal fluid.
Historically the prognosis has been dismal,
with a median survival of only 8 months
in one large series (Nathwani et al., 1976).
With modern intensive therapy, however,
of the type used for acute lymphoblastic
leukaemia, the outlook has improved
markedly (Weinstein et al., 1979). The
tumours are composed ofrelatively mono-
morphic cells with sparse cytoplasm and
round or convoluted nuclei. Chromatin is
delicately stippled and evenly distributed,
and nucleoli are usually small and in-
conspicuous. In a majority of cases one
can identify, with a 1OOX oil-immersion
objective, variably numerous cells with
convoluted nuclear infoldings and lobula-
tions. Mitotic figures are numerous and
may be accompanied by a "starry-sky"
pattern of interspersed macrophages iden-
tical to those of Burkitt's tumour.
The frequent association of lympho-
blastic lymphoma with an anterior medias-
tinal mass at presentation led early on to
the suggestion of a link between this
tumour and the thymus gland (Webster,
1961). Moreover, the observation of selec-
tive neoplastic infiltration of the para-
cortical T cell regions ofpartially involved
lymph nodes strengthened the hypothesis
that this lymphoma was closely related to
T lymphocytes. In view of these indirect
observations it is not surprising that T-
cell markers have been identified in most
cases. The malignant cells have in par-
ticular the surface, cytochemical and bio-
chemical features ofimmature thymocytes
(Kaplan et al., 1974; Gatien et al.,
1975; Coccia et al., 1976; Jaffe et al.,
1976; Stein et al., 1976; Donlon et al.,
1977; Stein & Muller-Hermelink, 1977;
Kersey et al., 1978; Kung et al., 1978;
Lukes et al., 1978a, b; Bollum, 1979; Long
et al., 1979). The marked propensity for
progression to leukaemia establishes a
continuum between these tumours and a
subset of acute lymphoblastic leukaemia
(ALL), i.e., the 25% of cases of ALL with
T-cell markers (Kersey et al., 1973; Sen &
Borella, 1975; Tsukimoto et al., 1976).
The immunological, cytochemical and
biochemical features of 12 cases studied in
our laboratory are summarized in Table
IX. Nine of 12 (75%) were males and all
but one were aged 30 years or less. At
presentation 10/12 (83%) had anterior
mediastinal nmasses. In only 6/12 (50%0)
did the malignant cells manifest T markers
as defined by formation of E rosettes.
Perhaps if they had been studied for T-
cell-associated heteroantigens, more of
these cases would have been provably T
cell in nature. Complement receptors were
demonstrated in 5 cases (42%) and, in 3
of these, sheep-erythrocyte receptors and
complement receptors coexisted. Four
cases (33%h) had no demonstrable markers.
Cytochemical studies for acid phosphatase
(AP) were performed on 8 cases. Some
degree of AP activity was present in all
but the reaction was strong and sharply
localized only in cases with formation of
E rosettes by the neoplastic cells. Intense
punctate staining for AP has also been
reported in T-cell ALL (Catovsky et al.,
1974). In our series of lymphoblastic
lymphomas, cases which did not form E
rosettes tended to manifest AP activity
as a diffuse multigranular reaction. All
cases studied were positive for TdT
(Donlon et al., 1977; Bollum, 1979). The
heterogeneity of markers in this series
confirms our earlier experience (Jaffe et al.,
1976). Conceptually these tumours seem
to recapitulate different stages in the
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TABLE IX.-Markers of lymphoblastic lymphomas
Case No. Age/sex Me(l. mass Source E* EAC Slg
87
157
162
166
240
306
312
344
376
394
405
485
12F
23M
18M
22M
19M
60M
18M
30F
23M
22M
8F
25M
+
+
+
+
+
+
+
+
+
+
PB
PB
BM
PB
LN
Skin
PB
PF
PF
PF
LN
Tibia
BM
7
10
3
80t
7
20t
6
32t
23t
63t
70t
0
3
85t
9
4
70t
30t
9
3
34t
16t
NS
1
ND
4
8
8
0
0
0
0
ND
1
0
0
2
1
35
AP TdT
ND
ND
ND
ND
Mt
ND
Mt
Pt
Pt
Pt
Pt
MT
Mt
ND
ND
ND
ND
+ +
+
ND
* Results are expressed as % positive cells.
t Indicates marker identified on neoplastic cells.
t M =Multigranular reaction product; P =Punctate perinuclear reaction product.
Abbreviations: PF, pleural fluid; Med. mass, mediastinal mass; ND, not determined; NS, not satisfactory;
AP, acid phosphatase; TdT ,terminal deoxynucleotidyl transferase.
maturation of thymic lymphoblasts. As
with foetal thymocytes (Gatien et al.,
1975; Stein & Muller-Hermelink, 1977),
complement receptors seem to be present
on the most primitive cells and are lost
as the cells differentiate or "mature". TdT
is present in all cases but the development
of sharply localized acid phosphatase
activity seems to correlate with appear-
ance of the ability to form E rosettes.
Hodgkin's disease
Despite impressive clinical advances in
the diagnosis, staging, and therapy of
patients with H.D. there is still no
definitive evidence for the nature of the
neoplastic cells in this condition (Long,
1979). Because ofthe complex composition
of the cellular proliferation, there are
unavoidable difficulties in isolating and
characterizing the neoplastic cells. In
most non-Hodgkin's lymphomas and leu-
kaemias, the malignant populations are
fairly homogeneous and studies of cellular
suspensions may readily reveal their
nature. In contrast, H.D. is composed of
individual malignant cells distributed
amidst presumed reactive elements which
usually comprise the bulk of the tumefac-
tion. This interaction of reactive and
malignant cells has been confirmed by
the documentation of both euploid and
aneuploid populations in H.D. lesions
(Peckham & Cooper, 1969). For these
2
reasons, aggregated numerical data
gleaned from cellular suspensions of in-
volved tissues do not necessarily reflect
specific markers on the neoplastic cells.
Such mixed populations can be assessed
accurately only with a combination of
morphological, immunological, and cyto-
chemical techniques. Meaningful studies
are further hampered by the considerable
difficulties encountered in attempting to
harvest adequate numbers of malignant
cells from H.D. tissue, perhaps due to the
fragile nature of such cells and/or the
fibrosis common in these lesions (Leech,
1973; Braylan et al., 1974). In an attempt
to circumvent these problems, some in-
vestigators have recently tried to charac-
terize the neoplastic cells either in situ
(i.e., in frozen or paraffin-embedded tissue
sections) or in long-term tissue culture.
Although classically interpreted on mor-
phological grounds as probably deriving
from "reticulum cells" or histiocytes
(Rappaport, 1966) Reed-Sternberg cells
in early histochemical studies lacked the
enzymatic apparatus of cells of the
monocyte-macrophage series (Dorfman,
1961). With the realization in recent years
that, in response to mitogens or specific
antigens, B and T lymphocytes can trans-
form to large cells with vesicular nuclei,
prominent nucleoli, and deeply basophilic
cytoplasm, the suggestion has been made
that the malignant cells of H.D. may
15C. W. BERARD, J. COSSMAN AND E. S. JAFFE
actually derive from transformed lympho-
cytes rather than histiocytes. Distinct
similarities between Reed-Sternberg cells
and transformed lymphocytes have been
demonstrated ultrastructurally (Glick et
al., 1976).
H.D. shows strong evidence ofaderange-
ment of the T-cell limb of the immune
system (Long, 1979). Untreated patients
with newly diagnosed and even localized
disease may exhibit functionally deficient
T-cell-mediated immune responses, such
as impaired delayed hypersensitivity
(Young et al., 1973) prolonged retention of
cutaneous grafts (Kelly et al., 1960),
and increased susceptibilitv to certain
infectious organisms (Casazza et al., 1966).
Levels of E-rosette-forming cells in the
peripheral blood are often reduced, per-
haps due to circulating soluble factors.
The defect in formation of E rosettes can
be abolished by incubation in tissue cul-
ture medium with 20% foetal calf serum;
it can be reinduced by incubation in sera
from H.D. patients. Such sera, however,
do not exert this effect on T lymphocytes
from control patients (Fuks et al., 1976).
Also linking H.D. to the T-cell system is
the often striking preferential localization
of tumour within thymic-dependent para-
cortical regions of partially involved
lymph nodes. On the basis ofthese indirect
clues, some investigators have suggested
that the Reed-Sternberg cell is a trans-
formed T lymphocyte, perhaps anti-
genically altered by viral infection (Order
& Hellman, 1972; DeVita, 1973; Binia-
minov & Ramot, 1974). They have hypo-
thesized that H.D. represents a "civil
war" of interaction between antigenically
altered T lymphocytes and normal un-
infected lymphocytes. Although enticing,
this theory is devoid of any firm evidence.
Published immmunological studies of Reed-
Sternberg cells in suspension have failed
to demonstrate any markers of T lympho-
cytes (Boecker et al., 1975; Kay & Kadin,
1975; Schmitt et al., 1977; Stuart et al.,
1977).
The finding of immunoglobulins, both
within (Garvin et at., 1974: Taylor, 1974,
1976; Payne etal., 1976) and on the surface
(Kadin et al., 1974; Boecker et al., 1975) of
Reed-Sternberg cells, has prompted the
alternative notion that they are neoplastic
B lymphocytes. Wthilst isolated reports
exist of monoclonal cytoplasmic immuno-
globulin, most cases studied by either
immunoperoxidase techniques or immuno-
fluorescence have contained polyclonal
immunoglobulins (Garvin et al., 1974;
Taylor, 1974, 1976; Kadin et al., 1978;
Poppema et al., 1978). Certainly the mere
presence of immunoglobulin, without evi-
dence of endogenous synthesis, does not
identify a cellasaBlymphocyte. Receptors
for the Fc portion of IgG have been
demonstrated on Reed-Sternberg cells
(Jaffe et al., 1974b; Payne et al., 1976)
and recent in vitro studies have directly
documented the internalization of exo-
genous IgG and phagocytosis of immune
complexes by viable Reed-Sternberg cells
(Kadin et al., 1978). Additionally, patients
with active H.D. have been shown to have
circulating immune complexes (Amlot
et al., 1976). These complexes appear
to bind specifically to cell lines established
in long-term culture from spleens involved
by H.D. (Long et al., 1977a). Analogous
binding may occuir in vivo and account for
the presence of immunoglobulin on the
surface of and within the malignant cells.
There is thus no definitive proof of a
B-cell origin ofReed-Sternberg cells.
In vitro studies ofviable Reed-Sternberg
cells have suggested derivation from
macrophages (Kadin et al., 1978). Support
for this possibility has come from 3
laboratories independently studying long-
term cultures of cells established in vitro
from H.D. tumors (Kaplan & Gartner,
1977; Long et al., 1977b; Roberts et al.,
1978). The cultured cells cytologically
resemble Reed-Sternberg cells and their
mononuclear counterparts. They also fulfil
criteria of malignancy by being aneuploid
and heterotransplantable. All the cell lines
lack SIg, fail to form E rosettes, and
manifest to variable degrees cytochemical
and functional markers most consistent
with macrophages. These findings should
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be confirmed aiid extended, with particu-
lar emphasis on proving that the cultured
cells really are in vitro descendants of the
malignant cells of Hodgkin's disease. n
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